Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin for bleeding reduction during functional endoscopic sinus surgery
IRCT20170120032069N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of desmopressin in chronic rhinosinusitis (CRS) and chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Reduction of bleeding during surgery, Surgeon satisfaction with the surgical field and 1 more. Started Mar 2019; status: completed.
02
Drugs
desmopressin
03
Conditions
chronic rhinosinusitis (CRS)chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20170120032069N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170120032069N5.